Apellis Pharmaceuticals APLS
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2025Q4 | 25.12 | 370 | -15.29 | -59 | -5.52 | 1,075 |
| 2025Q3 | 22.63 | 401 | 77.39 | 216 | 22.95 | 1,059 |
| 2025Q2 | 17.31 | 156 | -26.30 | -42 | -5.18 | 821 |
| 2025Q1 | 21.87 | 164 | -46.96 | -92 | -10.90 | 807 |
| 2024Q4 | 31.91 | 229 | -15.61 | -36 | -4.07 | 885 |
| 2024Q3 | 28.84 | 237 | -22.91 | -57 | -6.36 | 902 |
| 2024Q2 | 38.36 | 264 | -14.18 | -38 | -4.34 | 904 |
| 2024Q1 | 58.78 | 267 | -28.80 | -66 | -8.20 | 832 |
| 2023Q4 | 59.86 | 195 | -41.51 | -89 | -11.02 | 789 |
| 2023Q3 | 38.04 | 232 | -48.55 | -140 | -16.18 | 818 |
| 2023Q2 | 91.10 | 345 | -32.22 | -122 | -12.88 | 916 |
| 2023Q1 | 65.96 | 412 | -61.09 | -178 | -20.44 | 979 |
| 2022Q4 | 51.71 | 170 | -69.56 | -166 | -20.33 | 760 |
| 2022Q3 | 68.30 | 307 | -59.60 | -191 | -20.40 | 873 |
| 2022Q2 | 45.22 | 334 | -39.16 | -156 | -14.52 | 1,002 |
| 2022Q1 | 50.81 | 462 | -42.04 | -139 | -13.70 | 1,146 |
| 2021Q4 | 47.28 | 199 | -148 | -21.02 | 882 | |
| 2021Q3 | 32.96 | -57 | -196 | -31.91 | 526 | |
| 2021Q2 | 63.20 | -141 | -219 | -29.03 | 700 | |
| 2021Q1 | 42.91 | 52 | -143.36 | -184 | -20.74 | 810 |